Compass Therapeutics (CMPX) Return on Assets (2023 - 2025)
Historic Return on Assets for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to 0.4%.
- Compass Therapeutics' Return on Assets fell 800.0% to 0.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4%, marking a year-over-year decrease of 800.0%. This contributed to the annual value of 0.38% for FY2024, which is N/A changed from last year.
- Latest data reveals that Compass Therapeutics reported Return on Assets of 0.4% as of Q3 2025, which was down 800.0% from 0.54% recorded in Q2 2025.
- Compass Therapeutics' Return on Assets' 5-year high stood at 0.26% during Q4 2023, with a 5-year trough of 0.54% in Q2 2025.
- In the last 3 years, Compass Therapeutics' Return on Assets had a median value of 0.34% in 2024 and averaged 0.36%.
- Data for Compass Therapeutics' Return on Assets shows a peak YoY increase of -800bps (in 2025) and a maximum YoY decrease of -2400bps (in 2025) over the last 5 years.
- Over the past 3 years, Compass Therapeutics' Return on Assets (Quarter) stood at 0.26% in 2023, then plummeted by -40bps to 0.36% in 2024, then dropped by -11bps to 0.4% in 2025.
- Its last three reported values are 0.4% in Q3 2025, 0.54% for Q2 2025, and 0.43% during Q1 2025.